Award Announcements: MCRA

Parkinson Study Group: Mentored Clinical Research Award for new investigators in patient-oriented research in Parkinson’s disease and related disorders

The Mentored Clinical Research Award (MCRA) for new investigators is funded by a grant from the Parkinson’s Disease Foundation (PDF) to the Parkinson Study Group (PSG). The purpose of this grant is to support a new investigator for a 1 year project in patient oriented research in Parkinsons disease or other parkinsonian disorders under the mentorship of an experienced investigator. The goal of the Award is to provide funding for an investigator with the potential to become an independent researcher. Appropriate applicants for the MCRA are clinicians and scientists who are within 5 years of having completed formal training. The applicant must identify an appropriate mentor or mentors with extensive research experience.  Either the applicant or the mentor must be a member of the PSG.

Request for Proposals,

Application deadline: Monday, January 4, 2016

Award available: $50,000

Notification of award: March 1, 2016

The following investigators have been awarded (click on the project title for their abstract):
Tiago Mestre, MD, MSc, Parkinson's Disease and Movement Disorders Centre, Division of Neurology, Department of Medicine, University of Ottawa, Ontario, Canada: "Comparative evaluation of data-driven PD subtypes for clinical research".
Robert White, MD, PhD, Clinical Instructor, Department of Neurology, University of California, San Francisco: "A functional MRI study of dopamine's effects on the stability and flexibility of working memory in Parkinson disease".
Kristen Pickett, PhD, Postdoctoral Research Associate, Physical Therapy and Neurology, Washington University in Saint Louis: "Neurophysiologic adaptations to tango dancing in individuals with Parkinson disease".  
Joshua M. Shulman, MD, PhD, Associate Neurologist at Brigham and Women’s Hospital, Instructor in Neurology, Harvard Medical School, and Visiting Postdoctoral Fellow of Broad Institute of Harvard and MIT:  

“Genetic and Transcriptional Analysis of Susceptibility for Parkinson’s Disease Neuropathology”.




Jessica Calleo, PhD, Assistant Professor of Psychiatry and Behavioral Sciences at Baylor College of Medicine in Houston, Texas: “Behavioral Treatment of Anxiety in PD (BehTA-PD): A Pilot Study”. 

James T. Boyd, MD, Assistant Professor of Neurology, University of Vermont:
"Nicotine Treatment of Impulsivity in Parkinson's Disease: A Pilot Study".


Amie L. Peterson, MD, Movement Disorders Fellow, Oregon Health & Science University:
"A Pilot Study of Balance and Vitamin D in Persons with PD". 


Gregory Pontone, MD, Geriatric Psychiatry and Movement Disorders Research Fellow, Johns Hopkins University School of Medicine:
"Prevalence and familial aggregation of panic disorder in patients with Parkinson's disease"

Xiang Gao, MD, PhD, Nutritional Epidemiology Postdoctoral Fellow, Harvard School of Public Health:
“Prospective study of diet quality, dietary urate index and survival of PD patients”.
Vicki Shanker, MD, Movement Disorders Fellow, Beth Israel Medical Center:
“Defining the prevalence and phenotype of the leucine-rich repeat kinase (LRRK2) in Ashkenazi Jews”.

Connie Marras, MD, FRCP(C), Clinical Movement Disorders and Epidemiology Fellow, Toronto Western Hospital:
“A family study of LRRK2 mutations: Establishing evaluation and screening methods”. 


Wendy Galpern, MD, PhD, Movement Disorders Fellow, Toronto Western Hospital: 
"Antidyskinetic properties of topiramate:A double-blind, placebo-controlled trial in patients with Parkinson's disease and levodopa-induced dyskinesias". 


updated 10.10.14